BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38265849)

  • 1. Comparing the Efficacy of Targeted and Blast Portal Messaging in Message Opening Rate and Anticoagulation Initiation in Patients With Atrial Fibrillation in the Preventing Preventable Strokes Study II: Prospective Cohort Study.
    Kapoor A; Patel P; Chennupati S; Mbusa D; Sadiq H; Rampam S; Leung R; Miller M; Vargas KR; Fry P; Lowe MM; Catalano C; Harrison C; Catanzaro JN; Crawford S; Smith AM
    JMIR Cardio; 2024 Jan; 8():e49590. PubMed ID: 38265849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation.
    Kapoor A; Amroze A; Vakil F; Crawford S; Der J; Mathew J; Alper E; Yogaratnam D; Javed S; Elhag R; Lin A; Narayanan S; Bartlett D; Nagy A; Shagoury BK; Fischer MA; Mazor KM; Saczynski JS; Ashburner JM; Lopes R; McManus DD
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e005871. PubMed ID: 32063041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing preventable strokes: A study protocol to push guideline-driven atrial fibrillation patient education via patient portal.
    Fitzpatrick M; Sadiq H; Rampam S; Araia A; Miller M; Vargas KR; Fry P; Smith AM; Lowe MM; Catalano C; Harrison C; Catanzaro J; Crawford S; McManus D; Kapoor A
    Cardiovasc Digit Health J; 2022 Oct; 3(5):241-246. PubMed ID: 36310680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment of trial participants through electronic medical record patient portal messaging: A pilot study.
    Plante TB; Gleason KT; Miller HN; Charleston J; McArthur K; Himmelfarb CD; Lazo M; Ford DE; Miller ER; Appel LJ; Juraschek SP;
    Clin Trials; 2020 Feb; 17(1):30-38. PubMed ID: 31581836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.
    Lip GYH; Banerjee A; Boriani G; Chiang CE; Fargo R; Freedman B; Lane DA; Ruff CT; Turakhia M; Werring D; Patel S; Moores L
    Chest; 2018 Nov; 154(5):1121-1201. PubMed ID: 30144419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of Secure Messaging Through a Patient Portal as a Form of Outpatient Interaction across Clinical Specialties.
    Cronin RM; Davis SE; Shenson JA; Chen Q; Rosenbloom ST; Jackson GP
    Appl Clin Inform; 2015; 6(2):288-304. PubMed ID: 26171076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Assessment of Patient Portal Messaging Use by Patients With Multiple Chronic Conditions Living in Rural Communities: Retrospective Analysis.
    Chivela FL; Burch AE; Asagbra O
    J Med Internet Res; 2023 Aug; 25():e44399. PubMed ID: 37526967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.
    Roldán V; Cancio S; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Am J Med; 2015 Nov; 128(11):1237-43. PubMed ID: 26087049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Risk of Stroke Without Anticoagulation Therapy in Men and Women With Atrial Fibrillation Aged 66 to 74 Years Without Other CHA2DS2-VASc Factors.
    Abdel-Qadir H; Singh SM; Pang A; Austin PC; Jackevicius CA; Tu K; Dorian P; Ko DT
    JAMA Cardiol; 2021 Aug; 6(8):918-925. PubMed ID: 34009232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUPPORT-AF: Piloting a Multi-Faceted, Electronic Medical Record-Based Intervention to Improve Prescription of Anticoagulation.
    Kapoor A; Amroze A; Golden J; Crawford S; O'Day K; Elhag R; Nagy A; Lubitz SA; Saczynski JS; Mathew J; McManus DD
    J Am Heart Assoc; 2018 Sep; 7(17):e009946. PubMed ID: 30371161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Variation in Published Stroke Rates on the Net Clinical Benefit of Anticoagulation for Atrial Fibrillation.
    Shah SJ; Eckman MH; Aspberg S; Go AS; Singer DE
    Ann Intern Med; 2018 Oct; 169(8):517-527. PubMed ID: 30264130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of mHealth Devices to Screen for Atrial Fibrillation: Cost-Effectiveness Analysis.
    Giebel GD
    JMIR Mhealth Uhealth; 2020 Oct; 8(10):e20496. PubMed ID: 33021489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant).
    Gažová A; Leddy JJ; Rexová M; Hlivák P; Hatala R; Kyselovič J
    Medicine (Baltimore); 2019 Aug; 98(31):e16560. PubMed ID: 31374021
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.